144 related articles for article (PubMed ID: 19954279)
1. Surgical consolidation of initially unresectable urothelial carcinoma: an incremental opportunity to cure.
Siefker-Radtke AO
Expert Rev Anticancer Ther; 2009 Dec; 9(12):1701-3. PubMed ID: 19954279
[No Abstract] [Full Text] [Related]
2. Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery.
Chung SD; Lai MK; Chueh SC
BJU Int; 2008 Aug; 102(4):519. PubMed ID: 18699962
[No Abstract] [Full Text] [Related]
3. Management of upper urinary tract urothelial carcinoma.
Sun M; Abdo A; Abdollah F; Schmitges J; Thuret R; Jeldres C; Shariat SF; Perrotte P; Karakiewicz PI
Expert Rev Anticancer Ther; 2010 Dec; 10(12):1955-65. PubMed ID: 21110761
[TBL] [Abstract][Full Text] [Related]
4. Editorial Comment to Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of survival in patients with metastatic urothelial carcinoma: A multi-institutional study.
Mitsui Y
Int J Urol; 2015 Jul; 22(7):643-4. PubMed ID: 25903446
[No Abstract] [Full Text] [Related]
5. Clinical Trials Referral Resource. Clinical trials in bladder and urothelial cancers.
Kaplan RS; Cheson BD; Nelson AP
Oncology (Williston Park); 1997 Sep; 11(9):1348, 1351. PubMed ID: 9306423
[No Abstract] [Full Text] [Related]
6. [Urinary tract tumor registry].
vom Dorp F; Börgermann C; Goebell PJ; Schmid K; Siffert W; Rettenmeier AW; Rübben H
Urologe A; 2007 Sep; 46(9):1139-40. PubMed ID: 17641863
[No Abstract] [Full Text] [Related]
7. Aetiology, diagnosis and management of urothelial tumours of the renal pelvis and ureter.
Maddineni SB; Clarke NW; Sutherland DE; Jarrett TW
BJU Int; 2008 Nov; 102(9 Pt B):1302-6. PubMed ID: 19035896
[No Abstract] [Full Text] [Related]
8. Predictive factors for response and prognostic factors for long-term survival in consecutive, single institution patients with locally advanced and/or metastatic transitional cell carcinoma following cisplatin-based chemotherapy.
Jessen C; Agerbaek M; Von Der Maase H
Acta Oncol; 2009; 48(3):411-7. PubMed ID: 18798018
[TBL] [Abstract][Full Text] [Related]
9. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
[TBL] [Abstract][Full Text] [Related]
10. [Usefulness of radiotherapy in the treatment of infiltrating bladder cancer].
Escudero Barrilero A
Arch Esp Urol; 1990; 43 Suppl 2():165-84. PubMed ID: 1710884
[No Abstract] [Full Text] [Related]
11. Urothelial cancer: Optimizing and integrating cisplatin-based chemotherapy across the disease spectrum.
Raman JD
Nat Rev Urol; 2018 Mar; 15(3):139-140. PubMed ID: 29335525
[No Abstract] [Full Text] [Related]
12. Metastatic urothelial cancer: evaluation of prognostic factors and change in prognosis during the last twenty years.
Sengeløv L; Kamby C; von der Maase H
Eur Urol; 2001 Jun; 39(6):634-42. PubMed ID: 11464051
[TBL] [Abstract][Full Text] [Related]
13. Urothelial carcinoma of the upper urinary tracts: current knowledge and future perspectives.
Margulis V; Hutchinson R; Krabbe LM
Minerva Urol Nefrol; 2016 Aug; 68(4):348-9. PubMed ID: 27404376
[No Abstract] [Full Text] [Related]
14. [A clinical study on 34 cases of urothelial cancer of upper urinary tract].
Kyakuno M; Nojima M; Kondo N; Ito K; Sakai H; Kokado Y; Sagawa S; Shin T; Koto K
Hinyokika Kiyo; 1987 Dec; 33(12):1995-2000. PubMed ID: 3448924
[TBL] [Abstract][Full Text] [Related]
15. [Clinical studies of chemotherapy for patients with a solitary kidney after nephroureterectomy for advanced upper urothelial transitional cell carcinoma].
Tsujimura A; Takayama H; Tsukikawa M; Imazu T; Sugao H; Takaha M
Hinyokika Kiyo; 1995 Mar; 41(3):183-9. PubMed ID: 7741070
[TBL] [Abstract][Full Text] [Related]
16. Second-line therapies in metastatic urothelial carcinoma.
Narayanan S; Harshman LC; Srinivas S
Hematol Oncol Clin North Am; 2015 Apr; 29(2):341-59, x. PubMed ID: 25836939
[TBL] [Abstract][Full Text] [Related]
17. Salvage systemic therapy for advanced urothelial carcinoma: on the cusp of a sea change?
Sonpavde G; Bellmunt J
Oncologist; 2015 May; 20(5):461-3. PubMed ID: 25845991
[TBL] [Abstract][Full Text] [Related]
18. UTUC in 2017: Emerging evidence on treating upper tract urothelial cancer.
Grande P; Rouprêt M
Nat Rev Urol; 2018 Feb; 15(2):73-74. PubMed ID: 29182602
[No Abstract] [Full Text] [Related]
19. Changing concepts on pathology and therapy for transitional cell carcinoma.
Cummings KB
J Urol; 1995 Nov; 154(5):1717-8. PubMed ID: 7563330
[No Abstract] [Full Text] [Related]
20. Novel agents for muscle-invasive and advanced urothelial cancer.
Sonpavde G; Ross R; Powles T; Sweeney CJ; Hahn N; Hutson TE; Galsky MD; Lerner SP; Sternberg CN
BJU Int; 2008 Apr; 101(8):937-43. PubMed ID: 18005203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
